Browse by author
Lookup NU author(s): Dr Gajanan Sherbet
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Resveratrol (RES) is a natural occurring phytoalexin that has been shown to have chemopreventive activity. Resveratrol acts both by suppressing cell proliferation and inducing apoptosis in a variety of cancer cell lines. In this study, we show that RES induces apoptosis in MOLT-4 acute lymphoblastic leukaemia cells by modulating three different pathways that regulate cells survival and cell death. We show for the first time that RES inhibits the survival signalling pathways Notch and their down stream effector and modulates the operation of interacting signalling systems. It induces an increase in the levels of the pro-apoptotic proteins p53, its effector p21waf and Bax. We also show that RES inhibits the PI3K/Akt pathway and activates Gsk-3β. The data presented here demonstrate unequivocally that RES induces apoptosis by inhibiting the Notch pathway and markedly influencing the operation of the interacting apoptosis pathways mediated by p53 and PI3K/Akt. These data support findings from other laboratories that have suggested the use of RES as a chemopreventive agent. Here, we have identified potential signalling pathways influenced by RES and this could lead to the identification of the targets of RES-induced apoptosis and growth control. © 2007 Elsevier Inc. All rights reserved.
Author(s): Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet GV, Comi P
Publication type: Article
Publication status: Published
Journal: Biochemical Pharmacology
Year: 2007
Volume: 74
Issue: 11
Pages: 1568-1574
ISSN (print): 0006-2952
ISSN (electronic): 1873-2968
Publisher: Elsevier
URL: http://dx.doi.org/10.1016/j.bcp.2007.08.001
DOI: 10.1016/j.bcp.2007.08.001
PubMed id: 17868649
Altmetrics provided by Altmetric
